Do the tumor cells of hepatocellular carcinomas dislodge into the portal venous stream during hepatic resection?

Interferon-α and 5-fluorouracil combinat

Interferon-α and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules

✍ Hiroaki Nagano; Atsushi Miyamoto; Hiroshi Wada; Hideo Ota; Shigeru Marubashi; Yu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

## Abstract ## BACKGROUND. The authors reported previously the beneficial effects of interferon (IFN)‐α/5‐fluorouracil (5‐FU) combination therapy for patients with advanced hepatocellular carcinoma (HCC) who have tumor thrombi in the major portal branches. In this report, the authors describe the